The global non-invasive intracranial pressure monitoring market size was valued at USD 311.9 Million in 2022 and is likely to reach USD 496.7 Million by 2031, expanding at a CAGR of 6.6% during 2023 – 2031. The growth of the market is attributed to increasing demand for non-invasive monitoring systems for critical and complex medical surgeries.
Increasing incidences of traumatic brain injuries (TBI) caused by accidents and other reasons are resulting in rising demand for non-invasive monitoring solutions which further boost the non-invasive intracranial pressure monitoring market. Non-invasive ICP monitoring provides a safer and efficient way to track intracranial pressure without the need for invasive procedures.
-
A report published by the Centers for Disease Control and Prevention on September 7, 2023, shows that there were approximately 214,110 hospitalizations related to TBI in 2020 and around 69,473 deaths caused by TBI in 2021. This means that there were over 190 TBI-related deaths and 585 TBI-related hospitalizations per day.
Non-invasive intracranial pressure (ICP) monitoring is a well-known medical technique used to measure the pressure inside the skull while avoiding the need for invasive procedures. Unlike traditional invasive methods, this method is safer and reduces the complex life-threatening complications.
They help medical professionals assess and manage conditions that increase intracranial pressure, such as traumatic brain injuries, strokes, brain tumors, or infections. Moreover, by monitoring ICP, healthcare providers are easily able to detect changes in intracranial pressure early and take appropriate action to prevent further brain damage.
The research report finds that the COVID-19 pandemic hampered the market. During the pandemic major healthcare resources diverted towards managing COVID-19 cases. These further led to delays in non-emergency medical procedures and diagnostic tests, including non-invasive ICP monitoring.
This delay affected the overall demand for non-invasive ICP monitoring devices and services. Moreover, supply chain disruptions caused by the pandemic hindered the manufacturing and distribution of non-invasive ICP monitoring market.
Artificial Intelligence (AI) Impact on Non-Invasive Intracranial Pressure Monitoring Market
Emergence of artificial intelligence is expected to propel the market growth. AI algorithms have the ability to analyze complex data from non-invasive ICP monitoring devices accurately than human operators. This aids in the early detection of pressure changes and enables healthcare professionals to respond promptly to critical situations.
Furthermore, these advanced technologies automate routine tasks associated with non-invasive ICP monitoring, that reduces the task of healthcare staff from critical responsibilities.
Non-Invasive Intracranial Pressure Monitoring Market Dynamics
Major Drivers
Growing demand for the minimally invasive procedure is expected to drive the market. Patients are preferring less invasive procedures due to their safety benefits. The utilization of non-invasive or minimally invasive medical monitoring devices is increasing, as healthcare providers focus on patient-centric treatment. Moreover, the low risks and medical complications related to the use of non-invasive intracranial pressure monitoring devices is further boosting the market.
-
According to a report published by the National Library of Medicine on September 14, 2022, around 10% of surgeries for patients and nearly 20% of outpatient surgeries were considered minimally invasive surgeries between 2017 and 2018. Additionally, approximately 3% of operations involved the use of robotic assistance. The report also highlights that the volume of inpatient MIS cases has doubled from 1993 to 2014.
Existing Restraints
High implementation and maintenance costs associated with non-invasive ICP monitoring technologies are expected to hinder the market. This high cost limits the availability and accessibility of these advanced devices to healthcare providers and patients. It becomes difficult for hospitals and medical facilities to invest in modern technologies, which impacts their budget and affects the market growth.
Moreover, the lack of experienced healthcare experts with the necessary skills and knowledge to effectively use these non-invasive monitoring technologies is further decreasing their demand in the market.
Emerging Opportunities
Ongoing continuous research and development activities are expected to create favorable opportunities for the players competing in the market. Manufacturers are focusing on developing cost-effective and efficient non-invasive ICP monitoring solutions.
Innovations in materials, sensor technologies, and data transmission methods are resulting in accessible and practical devices. Furthermore, integrating non-invasive ICP monitoring into telehealth platforms for remote monitoring and consultations is propelling the market.
Scope of Non-Invasive Intracranial Pressure Monitoring Market Report
The report on the market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Non-Invasive Intracranial Pressure Monitoring Market- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Type (Tympanic Membrane Displacement, Magnetic Resonance Imaging & Computed Tomography, Transcranial Doppler Ultrasonography, Optic Nerve Sheath Diameter, and Fundoscopy) and Application (Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Traumatic Brain Injury, Meningitis, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Advanced Brain Monitoring, Inc; Compumedics Limited; Gaeltec Devices Ltd; GE Healthcare; Integra LifeSciences; Koninklijke Philips N.V.; RAUMEDIC AG; Natus Medical Incorporated; NovaSignal Corporation; NeuraSignal, Inc; NIHON KOHDEN CORPORATION; Sophysa; and Spiegelberg GmbH & Co. KG
|
Non-Invasive Intracranial Pressure Monitoring Market Segment Insights
Type Segment Analysis
Based on type, the non-invasive intracranial pressure monitoring market is divided into tympanic membrane displacement, magnetic resonance imaging & computed tomography, transcranial doppler ultrasonography, optic nerve sheath diameter, and fundoscopy.
The magnetic resonance imaging & computed tomography segment is expected to hold a major market revenue share during the forecast period, due to their exceptionally precise imaging of the brain's structure and fluid dynamics.
They provide detailed real-time insights into the intracranial environment which makes them essential for accurately assessing intracranial pressure. Moreover, the multi-modal capabilities of identifying brain lesions, tumors, or hemorrhages fuels their demand in the market.
The optic nerve sheath diameter (ONSD) segment is anticipated to register robust growth in the market, as it is readily accessible in healthcare facilities, making ONSD monitoring widely available. This ease of use and minimal equipment requirements make it a preferable choice for non-invasive intracranial pressure monitoring. Furthermore, rising demand for non-invasive or minimally invasive medical procedures is likely to boost the segment in the market.
Application Segment Analysis
In terms of application, the non-invasive intracranial pressure monitoring market is fragmented into intracerebral hemorrhage, subarachnoid hemorrhage, traumatic brain injury, meningitis, and others. The traumatic brain injury segment is expected to hold a key market share during the projected period, due to the increasing incidence of trauma cases due to accidents, falls, and sports-related injuries.
-
As per the Brain Injury Association of America, around 2.8 million Americans suffer from traumatic brain injuries every year. This amounts to approximately one in every 60 individuals. Furthermore, in North America, about 5.3 million people are living with a permanent disability caused by brain injury.
Non-invasive ICP monitoring is important for timely detection and management of elevated intracranial pressure in these patients. Moreover, non-invasive devices eliminate the need for invasive procedures assuring the safety of TBI patients which further boosts their demand in the market.
The intracerebral hemorrhage segment is projected to register a considerable CAGR during the forecast period, as monitoring intracranial pressure is crucial in ICH cases. This condition is life-threatening and requires non-invasive ICP monitoring devices for continuously assessing and managing pressure inside the body. Additionally, the advancement in non-invasive ICP monitoring is supporting its rising adoption in ICH patient healthcare settings.
Regional Analysis
In terms of region, the global non-invasive intracranial pressure monitoring market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market, owing to its relatively high healthcare expenditure enabling patients to access advanced medical services and technologies.
Non-invasive ICP monitoring system includes costly equipment and procedures that are readily accessible due to this robust healthcare funding. Furthermore, increasing patient demand for non-invasive approaches to their medical needs boosting the market in this region.
The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years, due to increasing investments in healthcare infrastructure, with the development of modern hospitals and medical facilities. This expansion helps these healthcare settings to the adoption of non-invasive ICP monitoring technologies. Furthermore, the growing prevalence of neurological disorders in this region propels the market.
- According to the report published by the National Library of Medicine on September 07, 2022, reported that South-East Asia and Western Pacific regions had 64.4 million and 85.0 million neurological disease-related disability-adjusted life years (DALYs) respectively.
Segments
The global non-invasive intracranial pressure monitoring market has been segmented on the basis of
Type
- Tympanic Membrane Displacement
- Magnetic Resonance Imaging & Computed Tomography
- Transcranial Doppler Ultrasonography
- Optic Nerve Sheath Diameter
- Fundoscopy
Application
- Intracerebral Hemorrhage
- Subarachnoid Hemorrhage
- Traumatic Brain Injury
- Meningitis
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Advanced Brain Monitoring, Inc
- Compumedics Limited
- Gaeltec Devices Ltd
- GE Healthcare
- Integra LifeSciences
- Koninklijke Philips N.V.
- RAUMEDIC AG
- Natus Medical Incorporated
- NovaSignal Corporation
- NeuraSignal, Inc
- NIHON KOHDEN CORPORATION
- Sophysa
- Spiegelberg GmbH & Co. KG
Competitive Landscape
Key players competing in the global non-invasive intracranial pressure monitoring market are Advanced Brain Monitoring, Inc; Compumedics Limited; Gaeltec Devices Ltd; GE Healthcare; Integra LifeSciences; Koninklijke Philips N.V.; RAUMEDIC AG; Natus Medical Incorporated; NovaSignal Corporation; NeuraSignal, Inc; NIHON KOHDEN CORPORATION; Sophysa; and Spiegelberg GmbH & Co. KG
These companies are propelling their market share by implementing various strategies such as partnerships, mergers, reduction in production costs, launching new products, and implementing advanced technologies.
- On March 15, 2022, NovaSignal Corporation, a medical technology manufacturer founded on brain healthcare, announced that Health Canada granted them a medical device license for their NovaGuide™ Intelligent Ultrasound. The Canadian healthcare practitioners uses NovaGuide to capture and monitor blood flow in the brain.
Request For Customization
Enquiry Before Buying
Speak With Analyst
